Founded in 2003, Yangzhou Princechem is a state-controlled national high-tech enterprise specializing in API intermediates and specialty generic drugs. Our products cover anti-cancer, cardiovascular, digestive, and mental health areas, with a portfolio of over 500 developed products. 

Operating from Yangzhou headquarters, the company follows a “1+3+N” industrial layout: 1 headquarters for R&D and business, 3 wholly-owned factories for intermediates and high-end CMO/CDMO services, and multiple equity-partnered enterprises to supplement production capacity.

We have earned National High-Tech Enterprise and “Little Giant” Specialized Innovation Enterprise titles, holds 141 patents (46 inventions), and implements ISO9001, ISO14001, and ISO45001 management systems.

We are a trusted supplier to leading domestic and international pharmaceutical companies, delivering high-quality products with innovation, reliability, and compliance at the core of our operations.